FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069626 [Registered on: 27/06/2024] Trial Registered Prospectively
Last Modified On: 20/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical Comparative study between efficiency of LMA-Supreme and I-Gel in adult patients undergoing elective surgery  
Scientific Title of Study   A Comparative Study between efficiency of LMA-Supreme and I-Gel in adult patients undergoing elective surgery  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Subhash Dahiya  
Designation  Professor  
Affiliation  LLRM Medical college  
Address  Department of Anaesthesia LLRM medical college Meerut Uttar Pradesh 250004 India

Meerut
UTTAR PRADESH
250004
India 
Phone  9837056949  
Fax    
Email  drsubhashllrm@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Subhash Dahiya  
Designation  Professor  
Affiliation  LLRM Medical college  
Address  Department of Anaesthesia LLRM medical college Meerut Uttar Pradesh 250004 India

Meerut
UTTAR PRADESH
250004
India 
Phone  9837056949  
Fax    
Email  drsubhashllrm@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Balsingh kethavath 
Designation  Junior Resident  
Affiliation  LLRM Medical college  
Address  Ground floor Department of Anaesthesia LLRM Medical college Meerut Uttar Pradesh

Meerut
UTTAR PRADESH
250004
India 
Phone  7569873634  
Fax    
Email  balsingh8411@gmail.com  
 
Source of Monetary or Material Support  
LLRM Medical college Department of Anaesthesia Meerut Uttar Pradesh 250004 
 
Primary Sponsor  
Name  LLRM Medical college  
Address  LLRM Medical college Department of Anaesthesia Meerut Uttar Pradesh 250004 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Subhash Dahiya   LLRM Medical college   Department of Anaesthesia LLRM Medical college Meerut Uttar Pradesh 250004
Meerut
UTTAR PRADESH 
9837056949

drsubhashllrm@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  ASA grade I and grade II undergoing elective surgery under general anaesthesia  
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  I-Gel   The I-Gel is the innovative second generation supraglottic airway device.Made from medical grade thermoplastic elastomer .I- Gel has been designed to create a non inflatable,anatomical seal of the pharyngeal ,laryngeal and peri pharyngeal structures while avoiding compression trauma.we compare various parameters every 5 min in first half an hour and every 30 min thereafter  
Intervention  Insertion of supraglottic airway devices  Comparison of various parameters like heamodynamic changes,Oropharyngeal airway seal pressure and other complications after insertion of SGA devices. We conducted this study over 2 years 
Comparator Agent  Supreme-LMA  Supreme-LMA is a single use second generation with gastric access device which forms an effective first seal with the oropharynx (oropharyngeal seal) and an innovative second seal with upper oesophageal sphincter (oesophageal seal).we compare various parameters every 5 minutes till first half an hour and every 30 min thereafter. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.ASA grade I and grade II patients
2.age 18-60 years of either sex
3.patients undergoing elective surgeries in supine position
4.patients with informed consent
5.BMI 18-25
6.Haemodynamically stable patients  
 
ExclusionCriteria 
Details  1.patient refusal
2.mallampatti grade III and IV
3.potentially full stomach patients
4.coagulation disorders
5.severe systemic disease  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Oropharyngeal seal pressure   After correct placement (around 10 min) 
 
Secondary Outcome  
Outcome  TimePoints 
Heart rate,SBP,DBP,oxygen saturation,post-op complications like sore throat,hoarseness and any injury   Base line,every 5 minutes of initial 15 minutes and then every 15 minutes till the end of surgery 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Comparative study between efficiency of Supreme-LMA and I-Gel in adult patients undergoing elective surgery .We conducted this study for 2 years.we compared changes in heamodynamic parameters,oropharyngeal airway seal pressure and other complications .conducted this study in healthy patients with minimum comorbidities. 
Close